Published in Clin Microbiol Infect on February 01, 2007
Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev (2008) 17.77
The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One (2010) 4.19
Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii? PLoS One (2010) 1.27
Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain. J Clin Microbiol (2010) 1.22
Use of the accessory genome for characterization and typing of Acinetobacter baumannii. J Clin Microbiol (2011) 1.16
Variable number tandem repeat loci providing discrimination within widespread genotypes of Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis (2008) 0.98
Association of biofilm production with colonization among clinical isolates of Acinetobacter baumannii. Korean J Intern Med (2016) 0.75
Acinetobacter baumannii: An Emerging and Important Pathogen. J Clin Outcomes Manag (2010) 0.75
Insights on the Horizontal Gene Transfer of Carbapenemase Determinants in the Opportunistic Pathogen Acinetobacter baumannii. Microorganisms (2016) 0.75
Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect (2007) 4.55
Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol (1995) 4.25
Amplified-fragment length polymorphism analysis: the state of an art. J Clin Microbiol (1999) 3.79
Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Clin Microbiol (1997) 3.57
Cell envelope protein profiles of Acinetobacter calcoaceticus strains isolated in hospitals. J Med Microbiol (1987) 2.78
Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol (2001) 2.49
Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol (1997) 2.45
Species, biotype, and bacteriophage type determinations compared with cell envelope protein profiles for typing Acinetobacter strains. J Clin Microbiol (1990) 2.32
Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit. J Clin Microbiol (1995) 2.15
Discrimination of Acinetobacter genomic species by AFLP fingerprinting. Int J Syst Bacteriol (1997) 2.01
Acinetobacter species identification by using tRNA spacer fingerprinting. J Clin Microbiol (1996) 1.99
A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect (2004) 1.74
Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula. J Antimicrob Chemother (2004) 1.72
Evaluation of the ability of a commercial system to identify Acinetobacter genomic species. Eur J Clin Microbiol Infect Dis (1996) 1.61
Control of an epidemic spread of a multi-resistant strain of Acinetobacter calcoaceticus in a hospital. Intensive Care Med (1989) 1.57
AFLP typing of Staphylococcus epidermidis in multiple sequential blood cultures. Res Microbiol (1998) 1.50
Survey of Klebsiella pneumoniae producing extended-spectrum beta-lactamases at a Portuguese hospital: TEM-10 as the endemic enzyme. J Antimicrob Chemother (2000) 1.48
Distribution and in-vitro transfer of tetracycline resistance determinants in clinical and aquatic Acinetobacter strains. J Med Microbiol (2000) 1.45
Endemic and epidemic acinetobacter species in a university hospital: an 8-year survey. J Clin Microbiol (2009) 1.43
Pillows, an unexpected source of Acinetobacter. J Hosp Infect (1995) 1.43
Recognition of two novel phenons of the genus Acinetobacter among non-glucose-acidifying isolates from human specimens. J Clin Microbiol (2000) 1.42
Acinetobacter species: which do we mean? Clin Infect Dis (1992) 1.36
Nosocomial outbreak of multi-resistant Acinetobacter baumannii on a surgical ward: epidemiology and risk factors for acquisition. J Hosp Infect (1997) 1.31
Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit. J Hosp Infect (2002) 1.29
Comparison of six media, including a semisolid agar, for the isolation of various Campylobacter species from stool specimens. J Clin Microbiol (1991) 1.28
RNA binding by the Wilms tumor suppressor zinc finger proteins. Proc Natl Acad Sci U S A (1996) 1.27
Specificity of rabbit antisera against lipopolysaccharide of Acinetobacter. J Clin Microbiol (1998) 1.22
Oil-degrading Acinetobacter strain RAG-1 and strains described as 'Acinetobacter venetianus sp. nov.' belong to the same genomic species. Res Microbiol (1999) 1.20
Outbreak of GES-1 beta-lactamase-producing multidrug-resistant Klebsiella pneumoniae in a university hospital in Lisbon, Portugal. Antimicrob Agents Chemother (2003) 1.15
Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS. Clin Microbiol Infect (2011) 1.14
High resolution DNA fingerprinting of Acinetobacter outbreak strains. FEMS Microbiol Lett (1996) 1.14
Structure and antimicrobial activity of diterpenes from the roots of Plectranthus hereroensis. J Nat Prod (1994) 1.13
Genotypic and phenotypic similarity of multiresistant Acinetobacter baumannii isolates in the Czech Republic. J Med Microbiol (1999) 1.12
Antimicrobial activity of Guinea-Bissau traditional remedies. J Ethnopharmacol (1996) 1.12
Persistent Acinetobacter baumannii? Look inside your medical equipment. Infect Control Hosp Epidemiol (2004) 1.10
Phenotypic characterisation of Acinetobacter strains of 13 DNA-DNA hybridisation groups by means of the biolog system. J Med Microbiol (1995) 1.09
Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999-2001. Clin Microbiol Infect (2006) 1.08
First description of CTX-M-15-producing Klebsiella pneumoniae in Portugal. Antimicrob Agents Chemother (2005) 1.07
Outbreak of septicaemia in neonates caused by Acinetobacter junii investigated by amplified ribosomal DNA restriction analysis (ARDRA) and four typing methods. J Hosp Infect (1997) 1.03
First isolation of bla(VIM-2) in Klebsiella oxytoca clinical isolates from Portugal. Antimicrob Agents Chemother (2005) 1.02
Evolutionary domestication in Drosophila subobscura. J Evol Biol (2007) 1.01
Case of aortic endocarditis caused by Lactobacillus casei. J Med Microbiol (2004) 1.00
Structural and serological characterisation of two O-specific polysaccharides of Acinetobacter. Eur J Biochem (1996) 0.99
Methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii: an unexpected difference in epidemiologic behavior. Am J Infect Control (1998) 0.98
Comparison of arbitrarily primed polymerase chain reaction and cell envelope protein electrophoresis for analysis of Acinetobacter baumannii and A. junii outbreaks. Res Microbiol (1996) 0.97
Widespread carbapenem resistant Acinetobacter baumannii clones in Italian hospitals revealed by a multicenter study. Infect Genet Evol (2011) 0.96
Outbreak of nosocomial meningitis caused by Acinetobacter baumannii in neurosurgical patients. J Hosp Infect (2004) 0.95
Molecular characterization of a ceftazidime-resistant Morganella morganii isolate producing a TEM-10 beta-lactamase. Antimicrob Agents Chemother (1999) 0.94
Cryptolepis sanguinolenta activity against diarrhoeal bacteria. J Ethnopharmacol (1994) 0.94
Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. J Cyst Fibros (2007) 0.93
Cystic fibrosis patients with the 3272-26A-->G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane. Hum Mutat (1999) 0.93
Genital mycoplasmas in women attending a family planning clinic in Guiné-Bissau and their susceptibility to antimicrobial agents. Acta Trop (2003) 0.92
Biofilm production by Staphylococcus epidermidis isolates associated with catheter related bacteremia. Diagn Microbiol Infect Dis (2000) 0.92
Epidemiologic typing of Escherichia coli using RAPD analysis, ribotyping and serotyping. Clin Microbiol Infect (2000) 0.92
Quorum sensing signal profile of Acinetobacter strains from nosocomial and environmental sources. Rev Argent Microbiol (2009) 0.91
Evaluation of the antiviral and antimicrobial activities of triterpenes isolated from Euphorbia segetalis. Nat Prod Res (2003) 0.91
Prenatal exposure to misoprostol and vascular disruption defects: a case-control study. Am J Med Genet (2000) 0.89
Global phylogeography and evolution of chelonid fibropapilloma-associated herpesvirus. J Gen Virol (2012) 0.89
Antimicrobial activity of Terminalia macroptera root. J Ethnopharmacol (1997) 0.88
Ureaplasma urealyticum biovar determination in women attending a family planning clinic in Guiné-Bissau, using polymerase chain reaction of the multiple-banded antigen gene. J Clin Lab Anal (2002) 0.88
In vitro antibacterial screening of Cryptolepis sanguinolenta alkaloids. J Ethnopharmacol (1994) 0.88
Acinetobacter baumannii-infected vascular catheters collected from horses in an equine clinic. J Clin Microbiol (2000) 0.87
Expression of hes6, a new member of the Hairy/Enhancer-of-split family, in mouse development. Mech Dev (2000) 0.86
Inflammatory bowel disease: a patient's and caregiver's perspective. Dig Dis Sci (2009) 0.85
Development of resistance to ciprofloxacin in Acinetobacter baumanii strains isolated during a 20-month outbreak. J Antimicrob Chemother (1997) 0.85
Performance of phenotypic and genotypic methods to determine the clinical relevance of serial blood isolates of staphylococcus epidermidis in patients with septicemia. J Clin Microbiol (2000) 0.85
Acinetobacter calcoaceticus-Acinetobacter baumannii complex species in clinical specimens in Singapore. Epidemiol Infect (2011) 0.85
Identification of multiresistant Staphylococcus epidermidis in neonates of a secondary care hospital using pulsed field gel electrophoresis and quantitative antibiogram typing. J Clin Pathol (1998) 0.85
High resolution DNA fingerprinting by AFLP to study the genetic variation among Oesophagostomum bifurcum (Nematoda) from human and non-human primates from Ghana. Parasitology (2005) 0.84
Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital. J Antimicrob Chemother (1998) 0.84
Acinetobacter junii causes life-threatening sepsis in preterm infants. Acta Paediatr (1999) 0.84
O-antigen diversity among Acinetobacter baumannii strains from the Czech Republic and Northwestern Europe, as determined by lipopolysaccharide-specific monoclonal antibodies. J Clin Microbiol (2001) 0.83
Species-specific ontogenetic diet shifts among Neotropical Crenicichla: using stable isotopes and tissue stoichiometry. J Fish Biol (2013) 0.83
An antimicrobial abietane from the root of Plectranthus hereroensis. Phytochemistry (1995) 0.82
Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and Portugal. Lupus (2009) 0.82
Transverse coloplasty pouch and colonic J-pouch for rectal cancer--a comparative study. Colorectal Dis (2003) 0.82
CGP 44532, a GABAB receptor agonist, is hedonically neutral and reduces cocaine-induced enhancement of reward. Neuropharmacology (2002) 0.81
Mechanisms of cardiac allograft prolongation by cyclosporin-A. Transplant Proc (1981) 0.81
A fertile male with cystic fibrosis: molecular genetic analysis. J Med Genet (1991) 0.81
Repression of promoters for the mouse insulin-like growth factor II-encoding gene (Igf-2) by products of the Wilms' tumour suppressor gene wt1. Gene (1995) 0.80
Association of Trichomonas vaginalis with sociodemographic factors and other STDs among female inmates in Lisbon. Int J STD AIDS (2004) 0.80
Arachidonic acid regulation of steroid synthesis: new partners in the signaling pathway of steroidogenic hormones. Endocr Res (2004) 0.80
Lonomia obliqua caterpillar spicules trigger human blood coagulation via activation of factor X and prothrombin. Thromb Haemost (1998) 0.80
Screening of antimicrobial activity of Cistus ladanifer and Arbutus unedo extracts. Nat Prod Res (2011) 0.80
Dissemination of Bacillus cereus in a paediatric intensive care unit traced to insufficient disinfection of reusable ventilator air-flow sensors. J Hosp Infect (2008) 0.80
Impaired IFN-α secretion by plasmacytoid dendritic cells induced by TLR9 activation in chronic idiopathic urticaria. Br J Dermatol (2011) 0.80
Can Escherichia coli be used as an indicator organism for transmission events in hospitals? Eur J Clin Microbiol Infect Dis (2008) 0.79
Persistence of uropathogenic Escherichia coli strains in the host for long periods of time: relationship between phylogenetic groups and virulence factors. Eur J Clin Microbiol Infect Dis (2011) 0.79
Geochemistry, mineralogy, solid-phase fractionation and oral bioaccessibility of lead in urban soils of Lisbon. Environ Geochem Health (2014) 0.78
[The RCT--the international rehabilitation and research center for torture victims. A presentation]. Ugeskr Laeger (1985) 0.78
Donor specific blood transfusions do not improve graft survival in living related donor transplantation. Transplant Proc (1987) 0.78
Prescription of antibiotics in intensive care units in Latin America: an observational study. J Chemother (2009) 0.78
Dynamics of Notch signalling in the mouse oviduct and uterus during the oestrous cycle. Reprod Fertil Dev (2015) 0.78
Optimum cycle time for intermittent UASB reactors treating dairy wastewater. Water Res (2005) 0.78
Can Nassarius reticulatus be used as a bioindicator for Hg contamination? Results from a longitudinal study of the Portuguese coastline. Mar Pollut Bull (2005) 0.78
Multifactorial origin of high incidence of Serratia marcescens in a cardio-thoracic ICU: analysis of risk factors and epidemiological characteristics. J Infect (2008) 0.77
[A peripheral neuroectodermal tumor of the vulva]. Acta Med Port (1995) 0.77
Enzymes involved in arachidonic acid release in adrenal and Leydig cells. Mol Cell Endocrinol (2007) 0.77